FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

2041000195100: Swiss German language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 07-Jun 2023. Module: SNOMED CT Switzerland NRC maintained Module

Descriptions:

Id Description Lang Type Status Case? Module
2101000195118 Swiss German language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
2111000195116 Swiss German language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
237221000195119 ensemble de référence pour la langue allemande suisse fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

78301 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Swiss German language reference set (foundation metadata concept) Is a German [International Organization for Standardization 639-1 code de] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
1. Trimester Preferred (foundation metadata concept)
1/24 Acceptable (foundation metadata concept)
1/3 Meter Preferred (foundation metadata concept)
1/36 Acceptable (foundation metadata concept)
1/60 Sehschärfe des linken Auges mit Korrektur Acceptable (foundation metadata concept)
1/60 Sehschärfe des rechten Auges mit Korrektur Acceptable (foundation metadata concept)
1/60 Visus des linken Auges mit Korrektur Preferred (foundation metadata concept)
1/60 Visus des rechten Auges mit Korrektur Preferred (foundation metadata concept)
11-Deoxykortikosteron erhöht Acceptable (foundation metadata concept)
11-Deoxykortikosteron erniedrigt Acceptable (foundation metadata concept)
11-Deoxykortikosteron innerhalb Referenzbereich Preferred (foundation metadata concept)
11-Deoxykortikosteron oberhalb Referenzbereich Preferred (foundation metadata concept)
11-Deoxykortikosteron unter Referenzbereich Acceptable (foundation metadata concept)
11-Deoxykortikosteron unterhalb Referenzbereich Preferred (foundation metadata concept)
11-Deoxykortikosteron über Referenzbereich Acceptable (foundation metadata concept)
11-Desoxy-17-Hydroxykortikosteron erhöht Acceptable (foundation metadata concept)
11-Desoxy-17-Hydroxykortikosteron erniedrigt Acceptable (foundation metadata concept)
11-Desoxy-17-Hydroxykortikosteron innerhalb Referenzbereich Preferred (foundation metadata concept)
11-Desoxy-17-Hydroxykortikosteron oberhalb Referenzbereich Preferred (foundation metadata concept)
11-Desoxy-17-Hydroxykortikosteron unter Referenzbereich Acceptable (foundation metadata concept)
11-Desoxy-17-Hydroxykortikosteron unterhalb Referenzbereich Preferred (foundation metadata concept)
11-Desoxy-17-Hydroxykortikosteron über Referenzbereich Acceptable (foundation metadata concept)
11-Desoxykortisol erhöht Acceptable (foundation metadata concept)
11-Desoxykortisol erniedrigt Acceptable (foundation metadata concept)
11-Desoxykortisol innerhalb Referenzbereich Acceptable (foundation metadata concept)
12-Kanal-EKG Acceptable (foundation metadata concept)
12-Kanal-Elektrokardiogramm Preferred (foundation metadata concept)
13-valente-Pneumokokken-Konjugatimpfung Acceptable (foundation metadata concept)
13-valenter Konjugatimpfstoff gegen Pneumokokken Preferred (foundation metadata concept)
13-valenter-Kapsel-Polysaccharid-Konjugatimpfstoff gegen Pneumokokken Acceptable (foundation metadata concept)
13-valenter-Pneumokokken-Konjugatimpfstoff Acceptable (foundation metadata concept)
14q32-Duplikationssyndrom Preferred (foundation metadata concept)
15q-Grosswuchs-Syndrom Preferred (foundation metadata concept)
17-Beta-Estradiol erhöht Acceptable (foundation metadata concept)
17-Beta-Estradiol erniedrigt Acceptable (foundation metadata concept)
17-Beta-Estradiol im Serum erhöht Acceptable (foundation metadata concept)
17-Beta-Estradiol im Serum erniedrigt Acceptable (foundation metadata concept)
17-Beta-Estradiol im Serum innerhalb Referenzbereich Acceptable (foundation metadata concept)
17-Beta-Estradiol innerhalb Referenzbereich Acceptable (foundation metadata concept)
17-Beta-Estradiol und follikelstimulierendes Hormon erhöht Acceptable (foundation metadata concept)
17-Beta-Östradiol erhöht Acceptable (foundation metadata concept)
17-Beta-Östradiol erniedrigt Acceptable (foundation metadata concept)
17-Beta-Östradiol im Serum erhöht Acceptable (foundation metadata concept)
17-Beta-Östradiol im Serum erniedrigt Acceptable (foundation metadata concept)
17-Beta-Östradiol im Serum innerhalb Referenzbereich Acceptable (foundation metadata concept)
17-Beta-Östradiol innerhalb Referenzbereich Acceptable (foundation metadata concept)
17-Beta-Östradiol und follikelstimulierendes Hormon erhöht Acceptable (foundation metadata concept)
17-KGS (17-ketogene Steroide) erhöht Acceptable (foundation metadata concept)
17-KGS (17-ketogene Steroide) erniedrigt Acceptable (foundation metadata concept)
17-KGS (17-ketogene Steroide) im Urin ausserhalb Referenzbereich Acceptable (foundation metadata concept)
17-KGS (17-ketogene Steroide) im Urin erhöht Acceptable (foundation metadata concept)
17-KGS (17-ketogene Steroide) im Urin erniedrigt Acceptable (foundation metadata concept)
17-KGS (17-ketogene Steroide) im Urin innerhalb Referenzbereich Acceptable (foundation metadata concept)
17-KGS (17-ketogene Steroide) innerhalb Referenzbereich Acceptable (foundation metadata concept)
17-Ketosteroide erhöht Acceptable (foundation metadata concept)
17-Ketosteroide erniedrigt Acceptable (foundation metadata concept)
17-Ketosteroide im Urin erhöht Acceptable (foundation metadata concept)
17-Ketosteroide im Urin oberhalb Referenzbereich Preferred (foundation metadata concept)
17-Ketosteroide im Urin über Referenzbereich Acceptable (foundation metadata concept)
17-Ketosteroide innerhalb Referenzbereich Preferred (foundation metadata concept)
17-Ketosteroide oberhalb Referenzbereich Preferred (foundation metadata concept)
17-Ketosteroide unter Referenzbereich Acceptable (foundation metadata concept)
17-Ketosteroide unterhalb Referenzbereich Preferred (foundation metadata concept)
17-Ketosteroide über Referenzbereich Acceptable (foundation metadata concept)
17-Oxosteroide erhöht Acceptable (foundation metadata concept)
17-Oxosteroide erniedrigt Acceptable (foundation metadata concept)
17-Oxosteroide im Urin erhöht Acceptable (foundation metadata concept)
17-Oxosteroide innerhalb Referenzbereich Acceptable (foundation metadata concept)
17-ketogene Steroide erhöht Acceptable (foundation metadata concept)
17-ketogene Steroide erniedrigt Acceptable (foundation metadata concept)
17-ketogene Steroide im Urin ausserhalb Referenzbereich Preferred (foundation metadata concept)
17-ketogene Steroide im Urin erhöht Acceptable (foundation metadata concept)
17-ketogene Steroide im Urin erniedrigt Acceptable (foundation metadata concept)
17-ketogene Steroide im Urin innerhalb Referenzbereich Preferred (foundation metadata concept)
17-ketogene Steroide im Urin oberhalb Referenzbereich Preferred (foundation metadata concept)
17-ketogene Steroide im Urin unter Referenzbereich Acceptable (foundation metadata concept)
17-ketogene Steroide im Urin unterhalb Referenzbereich Preferred (foundation metadata concept)
17-ketogene Steroide im Urin über Referenzbereich Acceptable (foundation metadata concept)
17-ketogene Steroide innerhalb Referenzbereich Preferred (foundation metadata concept)
17-ketogene Steroide oberhalb Referenzbereich Preferred (foundation metadata concept)
17-ketogene Steroide unter Referenzbereich Acceptable (foundation metadata concept)
17-ketogene Steroide unterhalb Referenzbereich Preferred (foundation metadata concept)
17-ketogene Steroide über Referenzbereich Acceptable (foundation metadata concept)
1p36-Deletionssyndrom Preferred (foundation metadata concept)
2- bis 3-mal wöchentlich Acceptable (foundation metadata concept)
2-Aminoadipin-2-Oxo-Adipin-Azidurie Preferred (foundation metadata concept)
2-Brom-2-Nitro-1,3-Propandiol Preferred (foundation metadata concept)
2-Hydroxy-4-methoxybenzophenon Acceptable (foundation metadata concept)
2-Hydroxybiphenyl Acceptable (foundation metadata concept)
2-Mercaptoethansulfonat-Natrium Acceptable (foundation metadata concept)
2-Methylbutyryl-CoA-Dehydrogenase-Mangel Preferred (foundation metadata concept)
2-Phenylphenol Preferred (foundation metadata concept)
2-Phenylphenolum Acceptable (foundation metadata concept)
2-Propanol Acceptable (foundation metadata concept)
2. Schwangerschaft Acceptable (foundation metadata concept)
2. Trimester Preferred (foundation metadata concept)
2/60 Sehschärfe des linken Auges mit Korrektur Acceptable (foundation metadata concept)
2/60 Sehschärfe des rechten Auges mit Korrektur Acceptable (foundation metadata concept)
2/60 Visus des linken Auges mit Korrektur Preferred (foundation metadata concept)
2/60 Visus des rechten Auges mit Korrektur Preferred (foundation metadata concept)
23-valente-Pneumokokken-Konjugatimpfung Acceptable (foundation metadata concept)

Page 1 of 784 Next End

Reference Sets

Reference set descriptor

GB English

US English

Back to Start